Advancing equity in the promise of pharmacogenomics

Alison E. Fohner, Shayna R. Killam, Kyle G. Volk, Erica L. Woodahl

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Scopus citations

Abstract

There is great potential benefit in using genetics to guide drug dosage and choosing the correct medications for patients. The prior chapters introduce clinical decision support (CDS) as a tool to guide clinicians in using pharmacogenomic tests to guide care. The goal of this chapter is to bring attention to the inequity in access to pharmacogenomic implementation efforts and how CDS can address this issues. To realize the benefits of pharmacogenomic CDS and to contribute to health equity, we urge teams implementing pharmacogenomic CDS to embrace transparency and education, and to utilize a learning health system approach to continuously gather data and fill in existing gaps in pharmacogenomics knowledge.

Original languageEnglish
Title of host publicationClinical Decision Support for Pharmacogenomic Precision Medicine
Subtitle of host publicationFoundations and Implementation
PublisherElsevier
Pages85-106
Number of pages22
ISBN (Electronic)9780128244531
ISBN (Print)9780128244548
DOIs
StatePublished - Jan 1 2022

Keywords

  • Barriers
  • Digital divide
  • Disparities
  • Diversity
  • Equity
  • Ethics
  • Ethnicity
  • Genomics
  • Healthcare
  • Marginalized
  • Minorities
  • Patient education
  • Personalized medicine
  • Precision medicine
  • Race
  • Underrepresented

Fingerprint

Dive into the research topics of 'Advancing equity in the promise of pharmacogenomics'. Together they form a unique fingerprint.

Cite this